📋 Tender Overview
The subject of this publication is the conclusion of non-exclusive discount agreements according to § 130a Abs. 8 SGB V for medicines with the trade name Oralair(R), including corresponding parallel and re-imports. The contract will be concluded within the framework of an Open-House model, meaning that the contract conclusion is open to all interested pharmaceutical companies during the participation period, provided they meet and accept the participation requirements. It is noted that the purchase quantity is unknown, as it depends on demand and the development of the number of insured persons, the prescribing behavior of doctors, and the dispensing and stocking behavior of public pharmacies. Minimum purchase quantities are therefore not guaranteed. Oralair(R)
